Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)
Clinical trial NCT05716763 · COMPLETED
Trial details
- NCT number
- NCT05716763
- Sponsor
- Unither Pharmaceuticals, France
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-14
- Primary completion
- 2023-02-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.